Mallinckrodt Pharmaceuticals
MNK
#9868
Rank
A$6.86 M
Marketcap
$0.52
Share price
0.00%
Change (1 day)
N/A
Change (1 year)

Revenue for Mallinckrodt Pharmaceuticals (MNK)

Revenue in 2023 (TTM): A$2.90 Billion

According to Mallinckrodt Pharmaceuticals 's latest financial reports the company's current revenue (TTM ) is A$2.94 Billion. In 2022 the company made a revenue of A$2.81 Billion a decrease over the revenue in the year 2021 that were of A$3.04 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Mallinckrodt Pharmaceuticals from 2013 to 2023

Annual revenue

Year Revenue Change
2023 (TTM) A$2.90 B3.38%
2022 A$2.81 B-7.67%
2021 A$3.04 B5.84%
2020 A$2.87 B-36.27%
2019 A$4.51 B18.77%
2018 A$3.80 B-7.84%
2017 A$4.12 B-17.51%
2016 A$5.00 B-0.77%
2015 A$5.04 B43.92%
2014 A$3.50 B39%
2013 A$2.51 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
A$133.21 B 4,422.04%๐Ÿ‡บ๐Ÿ‡ธ USA
A$0.12 B-95.79%๐Ÿ‡บ๐Ÿ‡ธ USA
A$24.74 B 739.99%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
A$82.65 B 2,705.70%๐Ÿ‡บ๐Ÿ‡ธ USA